Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer\'s disease and major depressive disorder
BiologyFeb 13, 2025SUWON,South Korea,Feb. 12,2025-- This is an interview with Fescaro Chief Technology officer Lee Hyun-jung published in The Korea Herald:
BiologyFeb 13, 2025PRINCETON,N.J.,Feb. 12,2025-- OnCusp Therapeutics,Inc.,a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for
BiologyFeb 13, 2025Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM.
BiologyFeb 13, 2025YIWU,China,Feb. 12,2025-- On February 9,the 12th day of the Lunar New Year,Yiwu International Trade City marked the grand opening after 2025 Chinese new year,warmly welcoming global business leaders.
BiologyFeb 13, 2025
Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.
© ArinstarTechnology
Privacy Policy